Achieving High Outcomes for High Cost Populations

As Chief Transformation and Integration Officer, Anita Allemand, Pharm.D. is responsible for establishing and leading the overall transformation agenda for WBA. Allemand works closely with divisional executive leaders to ensure alignment across all transformation activities and initiatives, with a special focus on coordination and alignment of digital efforts.  A pharmacist by trade, prior to joining WBA, Allemand was Senior Vice President of Health Solutions for Optum, a UnitedHealth Group company, and before Optum she spent 16 years with CVS Health in a number of leadership positions with increasing responsibility, most recently serving as Senior Vice President, Product Innovation and Development. Allemand graduated from University of Illinois and received her Doctor of Pharmacy from Midwestern University.  

Lorraine is a life sciences executive who creates new markets and fosters innovation.  She is author of The Innovation Mindset: Eight Essential Steps for Transforming Any Industry, scheduled for publication by Columbia University Press, August 2022.  As General Manager for Life Sciences at IBM Watson Health, she leads the organization in creating innovative solutions to deliver greater value from data, analytics and clinical development accelerators with a focus on improving treatment outcomes.  Previously, she led R&D Consulting at IQVIA and held executive roles at Cognizant Technology Solutions, Covance and Bristol Myers Squibb.  She co-founded four companies.  She is an adjunct professor and advisory board member, Healthcare and Pharmaceutical Management Program, Columbia Business School.  She is a mentor for the New York University Endless Frontier Labs and the University City Sciences Center, Philadelphia.

Rhonda L. Randall, D.O., is the chief medical officer of UnitedHealthcare Employer & Individual, a business segment of the nation’s largest health care company helping serve more than 26 million Americans. Dr. Randall collaborates with employers of all sizes to develop quality, cost-effective, long-term solutions for health benefits for their employees and retirees. She also leads clinical strategy development to help improve quality outcomes, promote affordability, and enhance health and well-being. Additionally, Randall supports the clinical strategy for UnitedHealth Group through her work in the company’s medical affairs office and as a senior medical adviser to the United Health Foundation. Dr. Randall is a fellowship-trained geriatrician with a focus on hospice and palliative medicine, and is board certified in family practice. She completed her internship, residency, chief residency and fellowship at Florida Hospital in Orlando.

As Global President of Inflammation & Immunology (I&I) at Pfizer, Mike Gladstone leads a purpose-driven group of colleagues with deep experience and relationships in Rheumatology, Gastroenterology and Dermatology. Pfizer I&I is known for leading brands that are game-changers and mainstays of treatment that enable day-to-day freedom for patients with immuno-inflammatory diseases, which can often be debilitating, disfiguring and distressing, dramatically affecting what patients can do.Mike’s career has spanned more than 25 years in the pharmaceutical industry at both Wyeth and Pfizer in the U.S. and Europe. Most recently, he was Global President of Internal Medicine at Pfizer, responsible for an $8 billion portfolio of medicines that targets the most prevalent health needs facing our society and includes cardio-metabolic and pain therapeutic areas.